During the past decade, Atlantic Clinical Cancer Research Unit conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Atlantic Clinical Cancer Research Unit" are "Non-small Cell Lung Cancer(NSCLC)" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Atlantic Clinical Cancer Research Unit" in a lesser frequency.

Most popular intervention types in "Atlantic Clinical Cancer Research Unit" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "AT13387" (1 trials), "Crizotinib" (1 trials), "Ipilimumab" (1 trials) and "Nivolumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlantic Clinical Cancer Research Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Atlantic Clinical Cancer Research Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Atlantic Clinical Cancer Research Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Atlantic Clinical Cancer Research Unit, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".